Recall: BMS Coumadin for Injection

The FDA has announced a recall by Bristol-Myers Squibb of six lots of Coumadin for Injection, 5 mg single-use vials because of particulate matter.  While the recall is not listed as Class I, the recall notice mentions the possibility of “serious and potentially fatal adverse reactions.”  For lot numbers and other details see http://www.fda.gov/Safety/Recalls/ucm403501.htm.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s